SciSight Ecosystem
WoS SCIE Q4Scopus Q3SCImago #11,544CAS 4区Hybrid

Aids Research and Human Retroviruses

Abbreviation (ISO):AIDS RES HUM RETROV
Country: United States•WoS SCIE Quartile: Q4•Scopus SJR: 0.516•SCImago Rank: #11,544•Identifier (ISSN):0889-2229(Print)/1931-8405(Online)•Articles / Year: 131•Estimated Publication Fee (APC): $2,994 USD
Clarivate IF (2026)Q4
1
↓ -0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
87

87 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate6.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
131articles/year
8.98% Gold OA•94.38% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 1)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 1)
🔵 Computed
20251.00đ
WoS Q4(IF: 1.1)
🔵 Computed
20241.00đ
WoS Q4(IF: 1.5)
🔵 Computed
20231.00đ
WoS Q4(IF: 1.5)
🔵 Computed
20221.00đ
WoS Q4(IF: 1.723)
🔵 Computed
20211.00đ
WoS Q4(IF: 2.205)
🔵 Computed
20191.00đ
WoS Q4(IF: 1.805)
🔵 Computed
20181.00đ
WoS Q4(IF: 1.935)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes. AIDS Research and Human Retroviruses coverage includes: HIV cure research HIV prevention science - Vaccine research - Systemic and Topical PreP Molecular and cell biology of HIV and SIV Developments in HIV pathogenesis and comorbidities Molecular biology, immunology, and epidemiology of HTLV Pharmacology of HIV therapy Social and behavioral science Rapid publication of emerging sequence information.

Topics Covered (Recognized by AI)
Medicine96%Biology95.1%Immunology87.3%Virology86%Genetics84.1%Chemistry67.3%Family medicine66.4%Human immunodeficiency virus (HIV)66%Biochemistry65.1%Virus57.2%Internal medicine48%Gene46.2%Pathology29.9%Antibody27.1%Immune system26.2%Antigen23.6%Viral disease23.5%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,544Scopus Q3SCImago Profile
Scopus Coverage:1987-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q3
0.516

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
100

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.32

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,994 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations412
3-Year Documents288
Citable Documents282

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate52.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ3
Infectious DiseasesQ3
VirologyQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Mary Ann Liebert Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1987
Editorial Address
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
IMMUNOLOGY
JCRSCIE
173/183Q4
INFECTIOUS DISEASES
JCRSCIE
127/141Q4
VIROLOGY
JCRSCIE
41/44Q4
IMMUNOLOGY
JCISCIE
160/183Q4
INFECTIOUS DISEASES
JCISCIE
121/141Q4
VIROLOGY
JCISCIE
37/44Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—300
20251.16769
20241.572158
20231.5100347
20221.72397589
20212.2051331,029
2020—1551,307
20191.8051772,081
20181.9351882,059
2017—1692,541
2016—2032,864
2015—1953,291
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Aids Research and Human Retroviruses

WoS Q4
012320182019202120222023202420251.10
Annual Impact Factor Metric
2025:1.1

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 825e18d2-3dbb-4803-bbef-27c541bc3e80
Database Updated: 2026-10-01